Selexipag is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension
This is the first peptide product approval from the USFDA received by Alembic Pharmaceuticals
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
Brimonidine Tartrate Ophthalmic Solution is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
Prazosin Hydrochloride Capsule is indicated for the treatment of hypertension, to lower blood pressure
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic, and prostate cancer
Subscribe To Our Newsletter & Stay Updated
